Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Gastric Band Removal Procedures Exceed Placements

By HospiMedica International staff writers
Posted on 05 Sep 2017
Since 2013, explantation of laparoscopic adjustable gastric banding (LAGB) has exceeded that of implantation procedures at academic centers, according to a new study.

Researchers at the University of California Irvine (UCI, USA) queried the Vizient database from 2007 through 2015 to identify patients with a primary diagnosis of obesity who had undergone LAGB implantation, revision, or explantation at academic medical centers in the United States. More...
The data were than analyzed to determine prevalence and outcomes of primary LAGB implantation, compared to revision or explantation, with outcomes measures including length of stay (LOS), intensive care unit (ICU) admission, morbidity, mortality, and cost.

The results revealed that 28,202 patients in the United States underwent LAGB implantation procedures between 2007 and 2015. During the same period, 12,157 people had their gastric bands removed. Trend analysis revealed that as of 2013, surgeons did more explantation procedures to take the gastric bands out than to put them in. LAGB revision or explantation was associated with longer LOS, higher rate of postoperative ICU admissions, and higher overall morbidity compared than implantation. There were no differences in death rates or costs, with both types of surgery averaging at USD 12,000. The study was published on July 25, 2017, in Journal of the American College of Surgeons.

“A newer alternative in weight–loss surgery, laparoscopic sleeve gastrectomy, appears to be safer and more effective [than LAGB], and may be driving this trend,” said senior author Ninh Nguyen, MD, chief of bariatric surgery at UCI. “Compared to the adjustable gastric banding, the laparoscopic sleeve gastrectomy is associated with improved weight loss and lower incidence of late complications. The late complication rate requiring revision after sleeve gastrectomy is one–fourth that of gastric banding.”

LAGB is designed to reduce the size of the stomach by placing a silicone band around the upper portion of the stomach, creating a small pouch that restricts the amount of food that can be consumed at one time, and increases the time taken for the stomach to empty. Better options for bariatric surgery include sleeve gastrectomy, biliopancreatic diversion with duodenal switch, and gastric bypass via Roux-en-Y gastric bypass (RYGBP). In the United States there has been a greater use of LAGB than other surgical procedures, probably due to the preconception that LAGB is a "simple and safer" option.

Related Links:
University of California Irvine


Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Gas Consumption Analyzer
Anesthetic Gas Consumption Analyzer
Silver Member
X-Ray QA Device
Accu-Gold+ Touch Pro
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: The 3D-printed microneedle patch boosts live-virus vaccine delivery (Photo courtesy of IIS/University of Tokyo)

3D-Printed Delivery System Enhances Vaccine Delivery Via Microneedle Array Patch

The COVID-19 pandemic underscored the need for efficient, durable, and widely accessible vaccines. Conventional vaccination requires trained personnel and cold-chain logistics, which can slow mass immunization... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.